Shufang Renault

1.1k total citations · 1 hit paper
17 papers, 683 citations indexed

About

Shufang Renault is a scholar working on Cancer Research, Oncology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Shufang Renault has authored 17 papers receiving a total of 683 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Cancer Research, 9 papers in Oncology and 7 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Shufang Renault's work include Cancer Genomics and Diagnostics (11 papers), Advanced Breast Cancer Therapies (3 papers) and Renal cell carcinoma treatment (2 papers). Shufang Renault is often cited by papers focused on Cancer Genomics and Diagnostics (11 papers), Advanced Breast Cancer Therapies (3 papers) and Renal cell carcinoma treatment (2 papers). Shufang Renault collaborates with scholars based in France, United States and Denmark. Shufang Renault's co-authors include Valérie Taly, Pierre Laurent‐Puig, Jörg Tost, Xavier Mariette, Gaëtane Nocturne, Saida Boudaoud, François‐Clément Bidard, Victor Renault, Caroline Hego and Chloé Dominici and has published in prestigious journals such as Nature Communications, Journal of Clinical Oncology and PLoS ONE.

In The Last Decade

Shufang Renault

16 papers receiving 677 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation

2023 148 citations Isabelle Bourget, Pascal Lopez et al. Cancer Cell profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Shufang Renault France	11	322	253	210	161	112	17	683
Rachel Koldej Australia	17	99 0.3×	293 1.2×	247 1.2×	162 1.0×	83 0.7×	59	771
Patricia Keith Australia	11	139 0.4×	270 1.1×	134 0.6×	59 0.4×	72 0.6×	15	568
Sissel Trachsel Norway	8	121 0.4×	311 1.2×	412 2.0×	335 2.1×	74 0.7×	8	732
Stephanie E. Weissinger Germany	13	81 0.3×	174 0.7×	277 1.3×	75 0.5×	76 0.7×	35	529
Gábor Sobel Hungary	12	196 0.6×	216 0.9×	132 0.6×	68 0.4×	65 0.6×	26	607
Miguel G. Silva Germany	9	350 1.1×	533 2.1×	160 0.8×	89 0.6×	69 0.6×	14	689
Hermann Brustmann Austria	18	88 0.3×	317 1.3×	270 1.3×	182 1.1×	95 0.8×	43	764
Antonella Zagaria Italy	23	242 0.8×	504 2.0×	132 0.6×	74 0.5×	57 0.5×	80	1.2k
Akimasa Hayashi Japan	17	200 0.6×	380 1.5×	310 1.5×	101 0.6×	193 1.7×	60	940
Loren E. Clarke United States	16	105 0.3×	283 1.1×	422 2.0×	80 0.5×	81 0.7×	41	677

Countries citing papers authored by Shufang Renault

Since Specialization

Citations

This map shows the geographic impact of Shufang Renault's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Shufang Renault with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Shufang Renault more than expected).

Fields of papers citing papers by Shufang Renault

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Shufang Renault. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Shufang Renault. The network helps show where Shufang Renault may publish in the future.

Co-authorship network of co-authors of Shufang Renault

This figure shows the co-authorship network connecting the top 25 collaborators of Shufang Renault. A scholar is included among the top collaborators of Shufang Renault based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Shufang Renault. Shufang Renault is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

Zhang, Diana, Shayesteh Jahanfar, Joshua Dower, et al.. (2025). Role of circulating tumor DNA in early-stage triple-negative breast cancer: a systematic review and meta-analysis. Breast Cancer Research. 27(1). 38–38. 1 indexed citations

Rodrigues, Manuel, Toulsie Ramtohul, Aurore Rampanou, et al.. (2024). Prospective assessment of circulating tumor DNA in patients with metastatic uveal melanoma treated with tebentafusp. Nature Communications. 15(1). 8851–8851. 12 indexed citations

Vasseur, Antoine, Luc Cabel, Caroline Hego, et al.. (2024). Fulvestrant and everolimus efficacy after CDK4/6 inhibitor: a prospective study with circulating tumor DNA analysis. Oncogene. 43(16). 1214–1222. 6 indexed citations

Mariani, Pascale, François‐Clément Bidard, Aurore Rampanou, et al.. (2023). Circulating Tumor DNA as a Prognostic Factor in Patients With Resectable Hepatic Metastases of Uveal Melanoma. Annals of Surgery. 278(4). e827–e834. 10 indexed citations

Vasseur, Antoine, Caroline Hego, Florence Lerebours, et al.. (2023). Abstract P5-02-19: ctDNA as dynamic marker of response to fulvestrant and everolimus in CDK4/6 inhibitor-pretreated ER+ HER2- metastatic breast cancer patients: a prospective study. Cancer Research. 83(5_Supplement). P5–2. 1 indexed citations

Bourget, Isabelle, Pascal Lopez, Julien Cherfils‐Vicini, et al.. (2023). Neutrophil extracellular traps formed during chemotherapy confer treatment resistance via TGF-β activation. Cancer Cell. 41(4). 757–775.e10. 148 indexed citations breakdown →

Pierga, Jean‐Yves, Tienhan Sandrine Dabakuyo‐Yonli, Jérôme Lemonnier, et al.. (2023). Abstract P4-07-24: Circulating tumor cells enumeration and Health Related Quality of Life of patients treated with first-line chemotherapy for HER2 negative metastatic breast cancer. Cancer Research. 83(5_Supplement). P4–7.

Stern, Marc‐Henri, Nicolas Kiavué, Luc Cabel, et al.. (2022). Microsatellite instability detection in breast cancer using drop-off droplet digital PCR. Oncogene. 41(49). 5289–5297. 12 indexed citations

Pietrasz, Daniel, Shufang Renault, Julien Taı̈eb, et al.. (2021). Prognostic value of circulating tumour DNA in metastatic pancreatic cancer patients: post-hoc analyses of two clinical trials. British Journal of Cancer. 126(3). 440–448. 33 indexed citations

10.

Renault, Shufang, et al.. (2020). 5-Aza-2′-deoxycytidine advances the epithelial–mesenchymal transition of breast cancer cells by demethylating Sipa1 promoter-proximal elements. Journal of Cell Science. 133(9). 10 indexed citations

11.

Wack, Maxime, Marion Mandavit, Sonia Garrigou, et al.. (2019). HPV circulating tumoral DNA quantification by droplet‐based digital PCR: A promising predictive and prognostic biomarker for HPV‐associated oropharyngeal cancers. International Journal of Cancer. 147(4). 1222–1227. 73 indexed citations

12.

Pietrasz, Daniel, Shufang Renault, Laëtitia Dahan, et al.. (2019). Methylated circulating tumor DNA (Met-DNA) as an independent prognostic factor in metastatic pancreatic adenocarcinoma (mPAC) patients.. Journal of Clinical Oncology. 37(15_suppl). 4136–4136. 3 indexed citations

13.

Blons, Hélène, Valérie Taly, Fanny Garlan, et al.. (2019). Plasma clearance ofRASmutation under therapeutic pressure is a rare event in metastatic colorectal cancer. International Journal of Cancer. 147(4). 1185–1189. 32 indexed citations

14.

Renault, Victor, Jörg Tost, Shufang Renault, et al.. (2017). aCNViewer: Comprehensive genome-wide visualization of absolute copy number and copy neutral variations. PLoS ONE. 12(12). e0189334–e0189334. 6 indexed citations

15.

Renault, Shufang, Saida Boudaoud, Gaëtane Nocturne, et al.. (2017). Deregulation of microRNA expression in purified T and B lymphocytes from patients with primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 77(1). 133–140. 78 indexed citations

16.

Laurent‐Puig, Pierre, et al.. (2017). Droplet-based digital PCR and next generation sequencing for monitoring circulating tumor DNA: a cancer diagnostic perspective. Expert Review of Molecular Diagnostics. 18(1). 7–17. 186 indexed citations

17.

Miceli‐Richard, Corinne, Shufang Renault, Saida Boudaoud, et al.. (2015). Overlap between differentially methylated DNA regions in blood B lymphocytes and genetic at-risk loci in primary Sjögren's syndrome. Annals of the Rheumatic Diseases. 75(5). 933–940. 72 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact